Ursosan Forte 500mg 30 tablets — Made in Czech — Free Delivery

Product description 

Ursosana ® tablets are used for the following indications:

• for the dissolution of X-ray negative cholesterol gallstones no larger than 15 mm in diameter in patients with a functioning gallbladder, despite the presence of gallstone(s) in it(s)
• for the treatment of biliary reflux gastritis;
• for the symptomatic treatment of primary biliary cirrhosis (PBC) in the absence of decompensated liver cirrhosis;
• for the treatment of hepatobiliary disorders in cystic fibrosis in children aged 6 to 18 years.

Compound

Active ingredient: ursodeoxycholic acid.

1 coated tablet contains 500 mg of ursodeoxycholic acid.

Excipients: corn starch, corn starch, sodium starch (type A), colloidal silicon dioxide, magnesium stearate, white shell 03B28796 (hypromellose 6, titanium dioxide (E171), macrogol 400).

Contraindications

• hypersensitivity to any substance that is part of the preparation;
• acute inflammation of the gallbladder or bile ducts;
• obstruction of the bile ducts (blockage of the common bile duct or duct)
• frequent episodes of hepatic colic;
• radiopaque calcified gallstones;
• violation of the contractile gallbladder;
• late stages of primary biliary cirrhosis due to insufficient therapeutic effect;
• use in children: unsuccessful result of portoenterostomy or lack of adequate biliary outflow in children with biliary atresia.

Mode of application

For patients whose body weight is less than 47 kg or who have difficulty swallowing capsules, it is recommended to use ursodeoxycholic acid in a different dosage form.

Peculiarities

pregnant

According to several recorded cases of the use of the preparation by breastfeeding, the content of ursodeoxycholic acid in milk was extremely low, therefore, the development of any adverse events in children receiving such milk should not be expected.

Children

There are no fundamental age restrictions for the use of Ursosan® forte in children, but children weighing less than 47 kg and / or children who have difficulty swallowing are recommended to use ursodeoxycholic acid in a different dosage form.

Drivers

There was no effect on the ability to drive a car and use mechanisms.

Overdose

In case of an overdose, diarrhea is possible. Other symptoms of overdose are unlikely because the absorption of ursodeoxycholic acid decreases with increasing dose, so most of the dose is excreted in the feces.

Side effects

From the gastrointestinal tract

Pasty stools or diarrhea have been frequently reported during clinical studies during treatment with ursodeoxycholic acid.

Very rarely, severe abdominal pain in the right hypochondrium was noted during the treatment of PBC.

From the side of the liver and gallbladder

Very rarely, calcification of gallstones is possible during treatment with ursodeoxycholic acid.

During the treatment of advanced stages of PBC, decompensation of liver cirrhosis is very rarely observed, partially decreases after treatment is stopped.

Hypersensitivity reactions

Allergic reactions are very rarely possible, including rash, urticaria.

Interaction

Ursodeoxycholic acid should not be co-administered with cholestyramine, colestipol, or antacids containing aluminum hydroxide and/or smectite (alumina), as these preparations bind ursodeoxycholic acid in the intestine and thus interfere with its absorption and reduce efficacy. If the use of preparations containing one of these substances is necessary, they must be taken at least 2:00 before or 2:00 after taking the preparation.

Storage conditions

Does not require special storage conditions. Keep out of the reach of children.

Shelf life: 4 years.